Cancer Center Support Grant - P30

癌症中心支持补助金 - P30

• 批准号: 7122157
• 负责人: Ralph W. deVere White
• 金额: $ 24.7万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-07-01 至 2006-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7122157
• 关键词: biomedical facility; cancer prevention; molecular oncology; neoplasm /cancer diagnosis; neoplasm /cancer therapy

DESCRIPTION (provided by applicant): The UC Davis Cancer Center, the only NCI-designated cancer center in the Central Valley of California, is the advanced cancer care provider for a population of five million, the only significance point of access to early phase cancer clinical trials in its Northern California region, and together with its collaborator, the Lawrence Livermore National Laboratory [LLNL], the region's principal cancer research organization. Since its founding thirteen years ago, the UC Davis Cancer Center has provided increasingly progressive leadership to, organization of, and support for cancer investigation. In the first sections, we recapitulate briefly the milestones leading up to NCI designation (July 1, 2002). In subsequent sections, we focus on decisions, achievements, and directions characterizing the center's first two years of its Cancer Center Support Grant [CCSG]. In concluding sections, we focus on program and organizational accomplishments, future direction, and geography.

描述(申请人提供)：加州大学戴维斯癌症中心是加州中央山谷唯一由NCI指定的癌症中心，是为500万人口提供高级癌症护理的机构，也是其北加州地区获得早期癌症临床试验的唯一重要途径，并与其合作者劳伦斯·利弗莫尔国家实验室[LLNL]一起，该地区的主要癌症研究机构。自13年前成立以来，加州大学戴维斯分校癌症中心为癌症研究提供了日益进步的领导、组织和支持。 在第一节中，我们简要回顾了NCI被指定为NCI之前的里程碑(2002年7月1日)。在接下来的部分中，我们将重点介绍该中心头两年的癌症中心支持拨款[CCSG]的决定、成就和方向。在结束语部分，我们将重点介绍计划和组织成就、未来方向和地理位置。